Elevation Oncology Inc. (NASDAQ: ELEV) Stock Information | RedChip

Elevation Oncology Inc. (NASDAQ: ELEV) Listen to this Section


$0.71
-0.0102 ( -1.41% ) 539.1K

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Market Data


Open


$0.71

Previous close


$0.72

Volume


539.1K

Market cap


$42.01M

Day range


$0.71 - $0.74

52 week range


$0.36 - $5.83

Insider Ownership Transactions

Total Amount Purchased: -290,424.00 | $ -206,723.80

Date Type Amount Purchased Purchaser
2024-06-18 Sale -12562.00 Ferra Joseph J Jr
2024-06-17 Sale -35000.00 Sandler Alan B.
2024-06-17 Sale -35000.00 Carruthers R Michael
2024-06-17 Sale -35000.00 Cherrington Julie M
2024-06-17 Sale -35000.00 CLACKSON TIMOTHY P
2024-06-17 Sale -35000.00 Mootz Darcy
2024-06-17 Sale -35000.00 ELMS STEVE
2024-05-17 Sale -300.00 Furlong Tammy
2024-03-19 Sale -12562.00 Ferra Joseph J Jr
2024-03-04 Sale -55000.00 Cherrington Julie M

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 75 Aug 06, 2024
8-k 8K-related 16 Aug 06, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 14 Jun 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.